Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A. J. Pantuck

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Lasers in Medical Science|January 16, 2007
Combined cytoreductive laser therapy and immunotherapy for palliation of metastatic renal cell carcinoma to the head and neckM B Paiva, J A Sercarz, A J Pantuck, et al.
The Journal of Urology|May 20, 1999
Female urethral adenocarcinoma: immunohistochemical evidence of more than 1 tissue of originD P Murphy, A J Pantuck, P S Amenta, et al.
Prostate Cancer and Prostatic Diseases|July 15, 2015
A randomized, double-blind, placebo-controlled study of the effects of pomegranate extract on rising PSA levels in men following primary therapy for prostate cancerA J Pantuck, C A Pettaway, R Dreicer, et al.
The Journal of Urology|September 24, 1999
Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostastic biopsy: a pilot studyM Perrotti, K R Han, R E Epstein, et al.
The Journal of Urology|July 4, 2001
Reevaluation of the 1997 TNM classification for renal cell carcinoma: T1 and T2 cutoff point at 4.5 rather than 7 cm. better correlates with clinical outcomeA Zisman, A J Pantuck, D Chao, et al.
Techniques in Urology|October 20, 1999
Endovascular stent graft for management of ureteroarterial fistula after orthotopic bladder substitutionK R Han, A J Pantuck, R L Siegel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Improved prognostication of renal cell carcinoma using an integrated staging systemA Zisman, A J Pantuck, F Dorey, et al.
The Journal of Urology|September 19, 2000
CL1-GFP: an androgen independent metastatic tumor model for prostate cancerB J Patel, A J Pantuck, A Zisman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2018
Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trialM Staehler, R J Motzer, D J George, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 18, 2010
[How radical nephrectomy compares to partial nephrectomy for the treatment of pT1a papillary renal cell carcinomas?]P Bigot, J-C Bernhard, M Crepel, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Lasers in Medical Science|January 16, 2007
Combined cytoreductive laser therapy and immunotherapy for palliation of metastatic renal cell carcinoma to the head and neckM B Paiva, J A Sercarz, A J Pantuck, et al.
The Journal of Urology|May 20, 1999
Female urethral adenocarcinoma: immunohistochemical evidence of more than 1 tissue of originD P Murphy, A J Pantuck, P S Amenta, et al.
Prostate Cancer and Prostatic Diseases|July 15, 2015
A randomized, double-blind, placebo-controlled study of the effects of pomegranate extract on rising PSA levels in men following primary therapy for prostate cancerA J Pantuck, C A Pettaway, R Dreicer, et al.
The Journal of Urology|September 24, 1999
Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostastic biopsy: a pilot studyM Perrotti, K R Han, R E Epstein, et al.
The Journal of Urology|July 4, 2001
Reevaluation of the 1997 TNM classification for renal cell carcinoma: T1 and T2 cutoff point at 4.5 rather than 7 cm. better correlates with clinical outcomeA Zisman, A J Pantuck, D Chao, et al.
Techniques in Urology|October 20, 1999
Endovascular stent graft for management of ureteroarterial fistula after orthotopic bladder substitutionK R Han, A J Pantuck, R L Siegel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Improved prognostication of renal cell carcinoma using an integrated staging systemA Zisman, A J Pantuck, F Dorey, et al.
The Journal of Urology|September 19, 2000
CL1-GFP: an androgen independent metastatic tumor model for prostate cancerB J Patel, A J Pantuck, A Zisman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2018
Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trialM Staehler, R J Motzer, D J George, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 18, 2010
[How radical nephrectomy compares to partial nephrectomy for the treatment of pT1a papillary renal cell carcinomas?]P Bigot, J-C Bernhard, M Crepel, et al.
Pageof 4